NBIX vs NG · P/E 45, rev $1.77B vs $1.96B cap
Neurocrine Biosciences Inc (NBIX) versus NovaGold Resources Inc (NG) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
NovaGold Resources Inc (NG) is a gold company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported NG revenue for 2026-05-31 was $0. Net income was -$40.9M. NG currently screens at market cap $1.96B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. NG currently screens at market cap $1.96B.
Not investment advice. Open the NBIX and NG stock pages for the full models.
Not investment advice.